Integrating EGFR Inhibitors into the Treatment of Metastatic Colorectal
Cancer

MONTREAL, Nov. 23 /CNW Telbec/ - The Canadian Oncology Societies (COS) and the Canadian Association of Medical Oncologists invite oncology professionals to participate in an interactive, on-line webinar on the topic of Integrating EGFR Inhibitors into the Treatment of Metastatic Colorectal Cancer: Current Evidence and Controversies, November 24, at 12 noon EST, featuring Dr. Scott Berry, Medical Oncologist, Sunnybrook Health Sciences Centre.

To register: https://orolab.ilinc.com/register/xyvjvvj

COS webinars are produced with unrestricted educational funding from Amgen, AstraZeneca, Boehringer Ingelheim, BMS, Novartis, Nycomed, Ortho Biotech, sanofi-aventis and Roche.

For further information:

Charles Pitts, 877 990 9044, [email protected]